TMPRSS2 inhibitors for the treatment of COVID-19 in adults: a systematic review and meta-analysis of randomized clinical trials of nafamostat and camostat mesylate

- Hernández-Mitre, María Patricia, Morpeth, Susan C., Roberts, Jason A., Venkatesh, Balasubramanian, Hills, Thomas E., Davis, Joshua, Mahar, Robert K., McPhee, Grace, Jones, Mark, Totterdell, James, Tong, Steven Y. C.

A Randomized Trial of Nafamostat for Covid-19

- Morpeth, Susan C., Venkatesh, Balasubramanian, Burke, Andrew J., Cochrane, Belinda, Denholm, Justin T., Dhungana, Ashesh, Dore, Gregory J., Dotel, Ravindra, Duffy, Eamon, Dummer, Jack, Foo, Hong, Gilbey, Timothy L., Totterdell, James A., Hammond, NE, Hudson, BJ, Jha, V, Jevaji, PR, John, O, Joshi, R, Kang, G, Kaur, B, Kim, S, Das, SK, McPhee, Grace M., Lau, JSY, Littleford, R, Marsh, JA, Marschner, IC, Matthews, G, Maze, MJ, McArthur, CJ, McFadyen, JD, McMahon, JH, McQuilten, ZK, Mahar, Robert K., Molton, J, Mora, JM, Mudaliar, V, Nguyen, V, O'Sullivan, MVN, Pant, S, Park, JE, Paterson, DL, Price, DJ, Raymond, N, Jones, Mark, Rees, MA, Robinson, JO, Rogers, BA, Ryu, W-S, Sasadeusz, J, Shum, O, Snelling, TL, Sommerville, C, Trask, N, Lewin, SR, Bandara, Methma, Hills, TE, Davis, Joshua S., Roberts, JA, Tong, SYC, Barina, Lauren A., Basnet, Bhupendra K., Bowen, Asha C.